UK NEQAS for Newborn Screening
Scheme Particulars | Indicative Details |
---|---|
Accreditation body | UKAS |
UKAS Accredited Proficiency Testing Provider No | 7860 |
Number of distributions per year (nominal) | 11 |
Specimens per distribution | 3 |
Frequency of distribution | Monthly |
Material distributed | Blood Spots |
Nominal sample volume (mL) | 0.035 per blood spot |
Programme Director(s) / Organiser(s) | Finlay MacKenzie |
Analyte | Approximate Range | Default Scheme Units |
---|---|---|
C10 | 0 – 6 | µmol/L WB |
C5 | 0 – 8 | µmol/L WB |
C5DC | 0 – 2 | µmol/L WB |
C8/C10 ratio | 0.1 – 30 | |
CF interpretation | N or P | |
CHT interpretation | N, B or P | |
Final C8 | 0 – 6 | µmol/L WB |
Final IRT | 10 – 200 | ng/mL [µg/L] WB |
Final Phe | 20 – 2000 | µmol/L WB |
Final TSH | 0 – 250 | mU/L WB |
Initial C8 | 0 – 6 | µmol/L WB |
Initial C8 interpretation | N or F | |
Initial IRT | 10 – 200 | ng/mL [µg/L] WB |
Initial IRT interpretation | N or F | |
Initial Phe | 20 – 2000 | µmol/L WB |
Initial Phe interpretation | N or F | |
Initial TSH | 0 – 250 | mU/L WB |
Initial TSH interpretation | N or F | |
Leu | 50 – 1200 | µmol/L WB |
MCADD interpretation | N or P | |
Met | 5 – 250 | µmol/L WB |
PKU interpretation | N, P or O | |
Tyr | 30 – 2000 | µmol/L WB |
- Download Newborn Screening 2024 schedule 53 KB